Cargando…

Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study

BACKGROUND: Hemodynamic changes have been observed in patients with Graves’ disease. The aim of our study was to evaluate choroidal vascular change using the choroidal vascularity index (CVI) in patients with thyroid-associated ophthalmopathy (TAO). METHODS: In this cross-sectional observational stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Loiudice, Pasquale, Pellegrini, Marco, Marinò, Michele, Mazzi, Barbara, Ionni, Ilaria, Covello, Giuseppe, Figus, Michele, Nardi, Marco, Casini, Giamberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086083/
https://www.ncbi.nlm.nih.gov/pubmed/33926559
http://dx.doi.org/10.1186/s40662-021-00242-6
_version_ 1783686454823616512
author Loiudice, Pasquale
Pellegrini, Marco
Marinò, Michele
Mazzi, Barbara
Ionni, Ilaria
Covello, Giuseppe
Figus, Michele
Nardi, Marco
Casini, Giamberto
author_facet Loiudice, Pasquale
Pellegrini, Marco
Marinò, Michele
Mazzi, Barbara
Ionni, Ilaria
Covello, Giuseppe
Figus, Michele
Nardi, Marco
Casini, Giamberto
author_sort Loiudice, Pasquale
collection PubMed
description BACKGROUND: Hemodynamic changes have been observed in patients with Graves’ disease. The aim of our study was to evaluate choroidal vascular change using the choroidal vascularity index (CVI) in patients with thyroid-associated ophthalmopathy (TAO). METHODS: In this cross-sectional observational study, 40 patients affected by TAO were recruited. Forty healthy individuals, matched for age and sex, served as controls. Foveal enhanced-depth imaging optical coherence tomography scans were obtained from all participants. Images were binarized using the ImageJ software and luminal area (LA) and total choroidal area (TCA) were measured. CVI was calculated as the proportion of LA to TCA. The relation between CVI or subfoveal choroidal thickness (SFCT) and clinical activity score, exophthalmometric value, diplopia status, gender, and age was evaluated. RESULTS: CVI was significantly higher in patients with TAO (P = 0.004). No significant difference was observed in SFCT (P = 0.200) and TCA (P = 0.153) comparing TAO patients and healthy controls. LA was significantly higher in TAO group (P = 0.045). On multiple regression analysis, CVI was associated with TCA (P = 0.043). No association was found between SFCT or CVI and TCA, clinical activity score, exophthalmometric value, Inami value, diplopia status, gender or age (P > 0.05). CONCLUSIONS: This is the first study that has demonstrated an increase in CVI in eyes with TAO compared with healthy controls and has assessed its association with clinical features.
format Online
Article
Text
id pubmed-8086083
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80860832021-04-30 Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study Loiudice, Pasquale Pellegrini, Marco Marinò, Michele Mazzi, Barbara Ionni, Ilaria Covello, Giuseppe Figus, Michele Nardi, Marco Casini, Giamberto Eye Vis (Lond) Research BACKGROUND: Hemodynamic changes have been observed in patients with Graves’ disease. The aim of our study was to evaluate choroidal vascular change using the choroidal vascularity index (CVI) in patients with thyroid-associated ophthalmopathy (TAO). METHODS: In this cross-sectional observational study, 40 patients affected by TAO were recruited. Forty healthy individuals, matched for age and sex, served as controls. Foveal enhanced-depth imaging optical coherence tomography scans were obtained from all participants. Images were binarized using the ImageJ software and luminal area (LA) and total choroidal area (TCA) were measured. CVI was calculated as the proportion of LA to TCA. The relation between CVI or subfoveal choroidal thickness (SFCT) and clinical activity score, exophthalmometric value, diplopia status, gender, and age was evaluated. RESULTS: CVI was significantly higher in patients with TAO (P = 0.004). No significant difference was observed in SFCT (P = 0.200) and TCA (P = 0.153) comparing TAO patients and healthy controls. LA was significantly higher in TAO group (P = 0.045). On multiple regression analysis, CVI was associated with TCA (P = 0.043). No association was found between SFCT or CVI and TCA, clinical activity score, exophthalmometric value, Inami value, diplopia status, gender or age (P > 0.05). CONCLUSIONS: This is the first study that has demonstrated an increase in CVI in eyes with TAO compared with healthy controls and has assessed its association with clinical features. BioMed Central 2021-04-30 /pmc/articles/PMC8086083/ /pubmed/33926559 http://dx.doi.org/10.1186/s40662-021-00242-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Loiudice, Pasquale
Pellegrini, Marco
Marinò, Michele
Mazzi, Barbara
Ionni, Ilaria
Covello, Giuseppe
Figus, Michele
Nardi, Marco
Casini, Giamberto
Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study
title Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study
title_full Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study
title_fullStr Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study
title_full_unstemmed Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study
title_short Choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study
title_sort choroidal vascularity index in thyroid-associated ophthalmopathy: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086083/
https://www.ncbi.nlm.nih.gov/pubmed/33926559
http://dx.doi.org/10.1186/s40662-021-00242-6
work_keys_str_mv AT loiudicepasquale choroidalvascularityindexinthyroidassociatedophthalmopathyacrosssectionalstudy
AT pellegrinimarco choroidalvascularityindexinthyroidassociatedophthalmopathyacrosssectionalstudy
AT marinomichele choroidalvascularityindexinthyroidassociatedophthalmopathyacrosssectionalstudy
AT mazzibarbara choroidalvascularityindexinthyroidassociatedophthalmopathyacrosssectionalstudy
AT ionniilaria choroidalvascularityindexinthyroidassociatedophthalmopathyacrosssectionalstudy
AT covellogiuseppe choroidalvascularityindexinthyroidassociatedophthalmopathyacrosssectionalstudy
AT figusmichele choroidalvascularityindexinthyroidassociatedophthalmopathyacrosssectionalstudy
AT nardimarco choroidalvascularityindexinthyroidassociatedophthalmopathyacrosssectionalstudy
AT casinigiamberto choroidalvascularityindexinthyroidassociatedophthalmopathyacrosssectionalstudy